SCHEMBL21708360

SCHEMBL21708360

CCc1ccc(N)c(-c2ccccc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
HSD17B10 Q99714 1/20 0.48
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MAPT P10636 2/20 0.47
LMNA P02545 1/20 0.47
MAPK1 P28482 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CYP1A2 P05177 1/20 0.44
CYP2A6 P11509 1/20 0.44
TP53 P04637 1/20 0.43
BACE1 P56817 1/20 0.42
PSMB5 P28074 1/20 0.41
CSNK2A1 P68400 2/20 0.41
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28171242 0.85 ALDH1A1 (0.48) ALDH1A1HSD17B10NPC1RAB9ASMN1; SMN2
SCHEMBL22043864 0.84 ALDH1A1 (0.52) ALDH1A1HSD17B10RAB9AMAPTBACE1
SCHEMBL23432416 0.84 SKP2 (0.59) ALDH1A1HSD17B10BACE1PSMB5SKP2
SCHEMBL3789650 0.82 CSNK2A1 (0.59) ALDH1A1HSD17B10BACE1CSNK2A1
SCHEMBL3783088 0.82 ALDH1A1 (0.50) ALDH1A1HSD17B10BACE1CSNK2A1
SCHEMBL8459740 0.82 MAPT (0.57) ALDH1A1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL28112852 0.81 USP7 (0.43) ALDH1A1HSD17B10MAPTLMNAMAPK1
SCHEMBL7443234 0.81 PSMB5 (0.52) ALDH1A1HSD17B10RAB9ASMN1; SMN2MAPT
SCHEMBL28184247 0.81 ALDH1A1 (0.48) ALDH1A1HSD17B10L3MBTL1CYP2A6BACE1
SCHEMBL27763835 0.80 TP53 (0.46) ALDH1A1HSD17B10NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174470-A1 COMPOUND AS A UBR BOX DOMAIN LIGAND AUTOTAC INC. (KR) 2023-06-08 US disclosed
US-20210107871-A1 BIARYL SULFONAMIDE DERIVATIVE HAVING FILOVIRUS CELL ENTRY INHIBITION ACTIVITY NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2021-04-15 US disclosed
EP-3611161-A1 BIARYL SULFONAMIDE DERIVATIVE HAVING FILOVIRUS CELL ENTRY INHIBITION ACTIVITY National University Corporation Hokkaido University (JP) 2020-02-19 EP disclosed
CN-101001887-B Multi-branched polymer and method for producing same NIPPON SODA CO.,LTD. (JP) 2012-02-08 CN disclosed
CN-101593852-B Multibranched polymers and process for production thereof NIPPON SODA CO 2011-03-02 CN disclosed
CN-101593852-A Multibranched polymers and manufacture method thereof NIPPON SODA CO (JP) 2009-12-02 CN disclosed
CN-101001887-A Multi-branched polymer and method for producing same NIPPON SODA CO (JP) 2007-07-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174470-A1 COMPOUND AS A UBR BOX DOMAIN LIGAND UBR4, UBQLN2, UBTF ALDH1A1 2317/4885HSD17B10 1933/4885NPC1 1751/4885
US-20210107871-A1 BIARYL SULFONAMIDE DERIVATIVE HAVING FILOVIRUS CELL ENTRY INHIBITION ACTIVITY FLNA, FLNB, BRI3BP ALDH1A1 2624/4885HSD17B10 2543/4885NPC1 49/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.